Figure 2From: Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemiaHbA1c (A); Fasting plasma glucose (B); Postprandial plasma glucose (C) and anamnestic hypoglycemia (within 12 months prior to baseline). Legend: none.Back to article page